Acumen Pharmaceuticals (ABOS) Stock Chart & Stock Price History $1.36 -0.06 (-4.23%) Closing price 04:00 PM EasternExtended Trading$1.38 +0.02 (+1.47%) As of 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acumen Pharmaceuticals Stock Price Performance The Acumen Pharmaceuticals (ABOS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 50.36%, with a year-to-date return of -20.93%. In the past month, the stock has increased 12.40%, reflecting recent market activity. As of the latest close, Acumen Pharmaceuticals traded at $1.42 with a market cap of $86.01 million and volume of 318,620 shares. Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.74%1 Month Performance+12.40%3 Month Performance+35.32%Year-To-Date Performance-20.93%1 Year Performance-50.36% ABOS Stock Chart for Friday, August, 8, 2025 ABOS Chart by TradingView Acumen Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$1.40$1.42+1.43%$1.47$1.37318,620 shs$86.01 million08/06/2025$1.36$1.40+2.94%$1.40$1.34146,341 shs$84.80 million08/05/2025$1.33$1.36+2.26%$1.41$1.31312,250 shs$82.38 million08/04/2025$1.35$1.33-1.48%$1.39$1.29176,163 shs$81.77 million08/01/2025$1.40$1.35-3.57%$1.39$1.3589,035 shs$81.77 million07/31/2025$1.46$1.40-4.11%$1.49$1.39154,755 shs$84.80 million07/30/2025$1.38$1.46+5.80%$1.60$1.41624,149 shs$88.43 million07/29/2025$1.46$1.38-5.48%$1.47$1.35242,157 shs$83.59 million07/28/2025$1.57$1.46-7.01%$1.62$1.44268,144 shs$88.43 million07/25/2025$1.61$1.57-2.48%$1.61$1.55164,550 shs$95.10 million Get the Latest News and Ratings for ABOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$1.68$1.61-4.17%$1.69$1.54532,962 shs$97.52 million07/23/2025$1.67$1.68+0.60%$1.78$1.67679,330 shs$101.76 million07/22/2025$1.55$1.67+7.74%$1.71$1.55503,490 shs$101.15 million07/21/2025$1.50$1.55+3.33%$1.58$1.49366,090 shs$93.88 million07/18/2025$1.48$1.50+1.35%$1.58$1.48511,937 shs$90.86 million07/17/2025$1.38$1.48+7.25%$1.55$1.40675,856 shs$89.65 million07/16/2025$1.31$1.38+5.34%$1.45$1.33412,186 shs$83.59 million07/15/2025$1.49$1.31-12.08%$1.44$1.263.42 million shs$79.35 million07/14/2025$1.40$1.49+6.43%$1.50$1.39539,703 shs$90.25 million07/11/2025$1.30$1.40+7.69%$1.47$1.311.46 million shs$84.80 million07/10/2025$1.25$1.30+4.00%$1.32$1.21361,418 shs$78.74 million07/09/2025$1.21$1.25+3.31%$1.27$1.23204,785 shs$75.71 million07/08/2025$1.16$1.21+4.31%$1.25$1.15377,826 shs$73.29 million07/07/2025$1.17$1.16-0.43%$1.18$1.14162,237 shs$70.27 million Related Companies NBTX Stock Chart RNAC Stock Chart RCKT Stock Chart CADL Stock Chart AMRN Stock Chart INBX Stock Chart NGNE Stock Chart IVA Stock Chart FDMT Stock Chart AVIR Stock Chart Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABOS) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acumen Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acumen Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
